Industry News: Volume 2, Issue 9

Recuro Health Elects Expanded 2022 Board of Directors, Announces Four High-Profile Industry Leaders as New Members

DALLAS–(BUSINESS WIRE)–Recuro Health (Recuro), an integrated digital health solutions company that transitions the U.S. healthcare system from a reactive, disease-focused model to a population health, outcomes approach, today announces the re-election of current leadership of its Board of Directors (BOD) and the addition of four incoming members. Effectively immediately, Michael Gorton, CEO, Recuro Health, and William Paiva, Ph.D., chairman of the BOD, will continue to serve, with an expanded BOD that includes highly respected industry leaders Tracy Chadwell, Kris EngskovPhilip Fasano and Bob Zollars.

The four new board members are:

  • Tracy Chadwell, founding partner of 1843 Capital, a venture capital fund focused on early-stage technology companies.
  • Kris Engskov, Co-Founder and CEO, Health-tech start-up currently in stealth mode, focused on building next-gen home health care delivery; former President U.S., Starbucks Coffee Company.
  • Philip Fasano, CEO. Bay Advisors LLC, a strategic advisory firm located in the Washington, DC area and operating nationally.
  • Bob Zollars, strategic advisor, Frazier Healthcare Partners, a leading provider of growth and venture capital to healthcare companies.

Gorton says, “These distinguished leaders bring diverse experience, perspectives and insight that will help advance Recuro’s growth. We look forward to applying their guidance and strategic thinking to serve the needs and expectations of providers, payers and patients in the adoption of Recuro’s curated and integrated suite of digital health solutions.”

Recuro addresses critical, real market challenges and impacts healthcare delivery at the intersection of quality, access and cost. From virtual primary care and behavioral telehealth to at-home testing and genetic screening, its fully customizable portfolio of digital health solutions can be tailored to meet the needs of any population.

Dr. Paiva says, “This expanded BOD takes us another step further in executing our vision to integrate high-impact digital health services across the full patient journey — from well care, pre-acute and acute care to post-acute care. The overwhelming response to Recuro among healthcare decision-makers and the investment community demonstrate market confidence in our business model and leadership team. Our commitment to innovation will bring more affordable, accessible healthcare to individuals nationwide.”

About Recuro Health

Serving payers, employers and providers, Recuro Health is an integrated digital health solution that delivers value throughout the healthcare ecosystem as care moves from traditional office in-person settings to wherever the patient and data are located. Recuro solutions support the migration from convenient care to meaningful patient engagement across broader care pathways, creating a personalized, holistic digital medical home that results in better outcomes and lower costs.

To view the original press release, click here.

Optime Care Collaborates with National Association of Specialty Pharmacy, Develops Podcast on Patient Journey Across Specialty Pharmacy & Healthcare

EARTH CITY, Mo.–(BUSINESS WIRE)–Optime Care, a nationally recognized specialty pharmacy, distribution and patient management organization maximizing therapeutic opportunities for the treatment of orphan and rare disorders, is pleased to announce that in collaboration with the National Association of Specialty Pharmacy (NASP), providers of networking, continuing education, pharmacist certifications and public policy advocacy for specialty pharmacy, Optime Care will develop and distribute a podcast with the Pharmacy Podcast Network. The series focuses on the patient journey mapping experience across the Specialty Pharmacy (SP) and healthcare spectrum, addressing internal and external factors that impact SP channel and services to the patient. This will include discussion moderated, by Michael Baldzicki, executive vice president of Growth & Strategy at AscellaHealth, about product criteria, price, site of care, clinical management, health plan design, complexity of administration, specialty handling, and overall patient compliance and engagement.

“Given today’s key SP trends, this podcast series could not be timelier or more impactful for patients, payers, life sciences and providers,” says Michelle Hefley, co-founder, managing partner and chairman, Optime Care. “The Specialty patient journey is complex and full of challenges, including rising costs of specialty agents and the emergence of ultra-high-cost specialty agents and cell/gene therapies for rare and orphan diseases. This demands more focused management of the high-cost specialty drug patients to ensure compliance and optimize outcomes. By talking to industry leaders, we will shed light on the best approach for enhancing quality of life for patients from the moment of diagnosis across the entire patient journey.”

Specific topics will include:

  • Understanding Patient Care Coordination Across the Healthcare Spectrum
  • Optimizing Specialty Pharmacy Health Outcomes
  • Navigating the Patient Journey in Specialty Pharmacy — from evaluation through treatment
  • How to Improve the Patient Experience and Why it Matters

“This collaborative initiative with NASP further underscores our dedication to providing education, insights and information for SP stakeholders,” Hefley adds. “It is also an opportunity to demonstrate the value of Optime Care capabilities, which span the entire product life cycle and prescription process. Our patient-first approach is streamlining communications between prescriber, patient and pharmacy to eliminate barriers, decrease time-to-fill, enhance the patient journey and optimize outcomes.”

The podcast series will feature four episodes, with the final episode recorded LIVE at the NASP 2022 Annual Meeting & Expo – Gaylord Palms Resort & Convention Center, Orlando, Florida, Sept. 19-22, 2022.

About Optime Care
Optime Care, Inc. is a nationally recognized specialty pharmacy, distribution and patient management organization offering a suite of comprehensive services tailored to maximize the therapeutic opportunities for the treatment of orphan and rare disorders. Our executive team has partnered in the launch and management of over 40 orphan products and programs while consistently implementing the best brand services for the community. Our experience with small patient populations, coupled with our strategic partnership with AscellaHealth, enhances our services and ability to serve the specialty pharmacy market. Optime Care has dual-accreditation from the Utilization Review Accreditation Commission (URAC) for compliance with specialty pharmacy and the Accreditation Commission for Health Care (ACHC) for specialty pharmacy services that demonstrate a commitment to providing quality care and services to consumers.

To view the original press release, click here.

Estimated 73% of US Now Immune to Omicron: Is That Enough?

By Carla K. Johnson, AP Medical Writer— The omicron wave that assaulted the United States this winter also bolstered its defenses, leaving enough protection against the coronavirus that future spikes will likely require much less — if any — dramatic disruption to society.

Millions of individual Americans’ immune systems now recognize the virus and are primed to fight it off if they encounter omicron, or even another variant.

To view the original article in its entirety, click here.

Covid Patients May Have Increased Risk of Developing Mental Health Problems

By Pam Belluk— Social isolation, economic stress, loss of loved ones and other struggles during the pandemic have contributed to rising mental health issues like anxiety and depression.

But can having Covid itself increase the risk of developing mental health problems? A large new study suggests it can.

To view the original article in its entirety, click here.  

Telehealth use for outpatient visits remains elevated, KFF study finds

By Anastassia Gliadkovskaya— Telehealth use has decreased since the start of the pandemic but levels remain elevated compared to pre-COVID levels, a new Kaiser Family Foundation analysis has found.

The survey assessed telehealth use from March 2019 through August 2021 using data from Cosmos, an Epic dataset, for more 41 million outpatient visits. 

To view the original article in its entirety, click here.

How many employees have hospitals lost to vaccine mandates? Here are the numbers so far

By Dave Muoio— The past several months have seen thousands of hospitals announce COVID-19 vaccination requirements for staff and clinicians as a condition of employment.

Although controversial, the policies picked up steam when Pfizer and BioNTech’s Comirnaty received a full regulatory approval. Mandate announcements really kicked into gear when the Biden administration made workforce vaccination a requirement for Medicare and Medicaid participation — a legally contentious decision that was ultimately upheld by the U.S. Supreme Court.

To view the original article in its entirety, click here.

U.S. Daily Coronavirus Deaths Show Modest Decline as Omicron Surge Wanes

By Cecelia Smith-Schoenwalder— Average daily deaths in the U.S. from the coronavirus are starting to decline, prompting cautious hope that the deadliest part of the latest wave fueled by the highly transmissible omicron variant is over.

Still, the number remains elevated. More than 2,000 people per day are dying from the coronavirus on average, according to data from the Centers for Disease Control and Prevention.

To view the original article in its entirety, click here.

Leave a Reply